Highland Private Wealth Management Gilead Sciences, Inc. Transaction History

Highland Private Wealth Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 08, 2020	SELL	$62.1 - $78.08 $214,493 - $269,688	-3,454 Closed	0 $0
Q2 2020 Jul 21, 2020	BUY	$72.34 - $84.0 $249,862 - $290,136	3,454 New	3,454 $266,000
Q4 2018 Feb 12, 2019	SELL	$60.54 - $79.0 $171,994 - $224,439	-2,841 Closed	0 $0
Q3 2018 Oct 17, 2018	BUY	$71.28 - $78.92 $202,506 - $224,211	2,841 New	2,841 $219,000
Q4 2017 Jan 26, 2018	SELL	$71.15 - $83.52 $200,358 - $235,192	-2,816 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$72.11 - $85.47 $203,061 - $240,683	2,816	2,816 $228,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Highland Private Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Highland Private Wealth Management with notifications on news.